Under construction – not a live service
Sign in
Taking people in SpainNo phase

Registry of adults with thyroid cancer treated in Spanish oncology services

Records the features of thyroid cancer in adults treated at Spanish cancer centers.

Plain-language title generated from the registry record
Registry title: GETNE Registration of Thyroid Cancer

Key facts

Where
Barcelona, SpainSee the site

Where in Spain

  • Hospital Universitari Vall d'HebronBarcelona, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Grupo Espanol de Tumores Neuroendocrinos
Trial code
NCT03765333
Record updated
22 September 2026
Original description
An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with diagnosis of primary thyroid cancer.Read full original descriptionShow less

Descriptive Observational Epidemiological Study on the Characteristics of Thyroid Cancer in Patients Treated in Oncology Services of Spanish Centers: National Registry of Thyroid Cancer - Differentiated, Medullary and Anaplastic

An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with diagnosis of primary thyroid cancer.

Inclusion: Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology; Patients who agree to participate and are able to understand the information sheet and sign the informed consent.

Exclusion: Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed; Patients under 18 years of age; Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.

ClinicalTrials.gov NCT03765333